Polarityte Inc., of Salt Lake City, said it registered Osteote with the FDA, pursuant to applicable regulations governing human cells, tissues and cellular and tissue-based products. Osteote is an autologous and homologous product intended to repair, reconstruct, replace and supplement many types of bones using a small sample from the patient.